Abstract
In chronic obstructive pulmonary disease (COPD), cognitive dysfunction - mainly of secondary memory, executive, and constructional abilities - is a marker of disease severity with important clinical and prognostic implications. It correlates with poor compliance with pharmacological therapy, and poor compliance, in turn, increases the cost/effectiveness ratio of home care programs. Executive dysfunction is associated with difficulty with inhaler devices and should be systematically evaluated before prescribing. Drawing impairment has been associated with mortality, although the underlying neurologic abnormalities (right insular damage with autonomic dysfunction or subcortical damage) remain to be defined. Depression is also negatively correlated with survival, besides being a risk factor for quitting respiratory rehabilitation. Cognitive dysfunction should always be considered among the systemic effects of COPD and be the object of systematic screening in COPD patients. Identifying cognitive impairment would prompt either interventions promoting the adherence to the therapy or further investigations to exclude respiratory (nocturnal or effort hypoxemia, coexistent obstructive sleep apnoea) or non respiratory (decompensated diabetes, hypoglycaemic crises, poorly controlled hypertension etc.) causes of cognitive dysfunction. Cognitive enhancing strategies deserve consideration in the framework of a comprehensive approach aimed at improving the health status of people with COPD.
Keywords: Cognitive impairment, depression, chronic obstructive pulmonary disease
Current Respiratory Medicine Reviews
Title: Clinical and Prognostic Implications of Cognitive Dysfunction and Depression in COPD
Volume: 3 Issue: 2
Author(s): Andrea Corsonello, Claudio Pedone and Raffaele Antonelli Incalzi
Affiliation:
Keywords: Cognitive impairment, depression, chronic obstructive pulmonary disease
Abstract: In chronic obstructive pulmonary disease (COPD), cognitive dysfunction - mainly of secondary memory, executive, and constructional abilities - is a marker of disease severity with important clinical and prognostic implications. It correlates with poor compliance with pharmacological therapy, and poor compliance, in turn, increases the cost/effectiveness ratio of home care programs. Executive dysfunction is associated with difficulty with inhaler devices and should be systematically evaluated before prescribing. Drawing impairment has been associated with mortality, although the underlying neurologic abnormalities (right insular damage with autonomic dysfunction or subcortical damage) remain to be defined. Depression is also negatively correlated with survival, besides being a risk factor for quitting respiratory rehabilitation. Cognitive dysfunction should always be considered among the systemic effects of COPD and be the object of systematic screening in COPD patients. Identifying cognitive impairment would prompt either interventions promoting the adherence to the therapy or further investigations to exclude respiratory (nocturnal or effort hypoxemia, coexistent obstructive sleep apnoea) or non respiratory (decompensated diabetes, hypoglycaemic crises, poorly controlled hypertension etc.) causes of cognitive dysfunction. Cognitive enhancing strategies deserve consideration in the framework of a comprehensive approach aimed at improving the health status of people with COPD.
Export Options
About this article
Cite this article as:
Corsonello Andrea, Pedone Claudio and Antonelli Incalzi Raffaele, Clinical and Prognostic Implications of Cognitive Dysfunction and Depression in COPD, Current Respiratory Medicine Reviews 2007; 3 (2) . https://dx.doi.org/10.2174/157339807780599162
DOI https://dx.doi.org/10.2174/157339807780599162 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Early Timing of Endovascular Treatment for Aneurysmal Subarachnoid Hemorrhage Achieves Improved Outcomes
Current Neurovascular Research New Pharmacologic Approaches to Prevent Thromboembolism in Patients with Atrial Fibrillation
Current Vascular Pharmacology Perivascular Adipose Tissue as an Endocrine Organ: The Role of Statins
Current Pharmaceutical Design Endocarditis Due to Salmonella Enterica Subsp. Arizonae in a Patient with Sickle Cell Disease: A Case Report and Review of the Literature
Cardiovascular & Hematological Disorders-Drug Targets Design and Development of Solid Dispersion of Valsartan by a Lyophilization Technique: A 3<sup>2</sup> Factorial Design Approach
Micro and Nanosystems Mild Cognitive Impairment: At the Crossroad of Neurodegeneration and Vascular Dysfunction
Current Alzheimer Research Brachial-Ankle Pulse Wave Velocity as a Novel Measure of Arterial Stiffness: Present Evidences and Perspectives
Current Hypertension Reviews Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Hypolipidemic, Antioxidant and Cardioprotective Effects of the Aqueous Extract from <i>Scorzanera Undulata</i> Tubers in Streptozotocin-Induced Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Disease More Effectively
CNS & Neurological Disorders - Drug Targets Medial Vascular Calcification in Diabetes Mellitus and Chronic Kidney Disease: The Role of Inflammation
Cardiovascular & Hematological Disorders-Drug Targets A Hopeful Prospect of Riociguat as a Soluble Guanylate Cyclase Stimulator for Management of Pressure Ulcers
Current Drug Discovery Technologies Patent Selections
Recent Patents on Cardiovascular Drug Discovery Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?
Current Pharmaceutical Design Genetics Talks to Epigenetics? The Interplay Between Sequence Variants and Chromatin Structure
Current Genomics Left Ventricular Hypertrophy in Isolated Aortic Stenosis: Primetime for the Ventricle
Current Pharmaceutical Biotechnology Low Baseline Urine Creatinine Excretion Rate Predicts Poor Outcomes among Critically Ill Acute Stroke Patients
Current Neurovascular Research Sequence Variants of the Ligand-Binding Domain of the Glucocorticoid Receptor Gene and their Functional Consequences on the Three- Dimensional Protein Structure
Current Medicinal Chemistry Hypertension, Cognitive Impairment and Dementia: An Epidemiological Perspective
Current Hypertension Reviews The Role of Oxidative Stress in Methamphetamine and MDMA-induced Toxicity
Mini-Reviews in Organic Chemistry